• Join
  • Login
  • Contact

Search abstracts

Cell-based gene therapies in oncology: Case study of the challenges of CAR-T therapy

  • In: Cell-based gene therapy - Promise and challenges on Wednesday, 25 September 2019, 9:00-12:00
  • At: AbuDhabi (United Arab Emirates) (2019)
  • Type: Presentation
  • By: KOLESAR, Jill (University of Kentucky, USA)
  • Abstract:

    CAR T therapy is a type of treatment in which a patient's T cells are removed via apheresis, sent to a processing laboratory and a chimeric antigen receptor (CAR) is introduced into the T cells, which allows the CAR T cell to identify and eliminate both malignant and normal cells that express a given antigen.   While multiple tumor antigens are


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses